Others had no significant changes, including KIAA1429, RBM15B, ZC3H13, CBLL1, ALKBH5, YTHDF1, YTHDF2, YTHDF3, IGF2BP1, and IGF2BP3 between NAFLD and control group. The gene discussed is RBM15B; the disease is metabolic dysfunction-associated steatotic liver disease.